Ad Scientiam launches U.S. subsidiary and expands deployment of MSCopilot® following FDA registration
Ad Scientiam announces the creation of its U.S. subsidiary, Ad Scientiam Inc., to support the deployment of MSCopilot® in the United States. PARIS, FRANCE, April 15, 2026 /EINPresswire.com/ -- Ad Scientiam, a global leader in digital biomarkers …